LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 90.55 | 27.76 | 8411 | 6928 | 1.2139 | 1.0493 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 90.55 | 27.76 | 2402 | 6928 | 0.3467 | 0.7509 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 90.55 | 27.76 | 9742 | 6928 | 1.4060 | 1.0874 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 92.25 | 27.76 | 1608 | 6873 | 0.2340 | 0.6661 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 92.25 | 27.76 | 8510 | 6873 | 1.2381 | 1.0545 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 92.25 | 27.76 | 1586 | 6873 | 0.2308 | 0.6632 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 92.25 | 27.76 | 9694 | 6873 | 1.4104 | 1.0884 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 93.96 | 27.76 | 1312 | 6849 | 0.1916 | 0.6245 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 93.96 | 27.76 | 8640 | 6849 | 1.2615 | 1.0593 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 93.96 | 27.76 | 1019 | 6849 | 0.1488 | 0.5736 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 93.96 | 27.76 | 9633 | 6849 | 1.4065 | 1.0877 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 95.66 | 27.76 | 1039 | 6712 | 0.1548 | 0.5801 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 95.66 | 27.76 | 8725 | 6712 | 1.2998 | 1.0673 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 95.66 | 27.76 | 533 | 6712 | 0.0794 | 0.4524 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 95.66 | 27.76 | 9684 | 6712 | 1.4427 | 1.0947 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 1.95 | 27.76 | 6 | 225 | 0.0267 | -0.3979 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 1.95 | 27.76 | 500 | 225 | 2.2208 | 1.6048 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 3.66 | 27.76 | 21 | 283 | 0.0740 | -0.0798 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 3.66 | 27.76 | 565 | 283 | 1.9899 | 1.4554 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 5.36 | 27.76 | 2 | 320 | 0.0062 | -0.5255 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 5.36 | 27.76 | 38 | 320 | 0.1186 | 0.0931 | MN20160318_Q01 | C22 |